From: CAM use among overweight and obese persons with radiographic knee osteoarthritis
Treatment use | CAM only | Conventional medications only | Both |
---|---|---|---|
Odds ratios | |||
(95% Confidence intervals) | |||
BMI ≥ 35 kg/m 2 versus referent group BMI <25 kg/m 2 | |||
Crude | 0.48 | 2.51 | 1.38 |
(0.31–0.73) | (1.55–4.07) | (0.94–2.04) | |
Socio-demographic adjusted† | 0.50 | 1.69 | 1.16 |
(0.28–0.91) | (0.81–3.53) | (0.65–2.09) | |
Socio-demographic and clinical characteristic adjusted†† | 0.47 | 1.13 | 0.55 |
(0.24–0.92) | (0.47–2.70) | (0.27–1.12) | |
BMI between 30 and <35 kg/m 2 versus referent group BMI <25 kg/m 2 | |||
Crude | 0.70 | 1.71 | 0.94 |
(0.50–0.98) | (1.09–2.68) | (0.66–1.34) | |
Socio-demographic adjusted† | 0.71 | 1.29 | 0.71 |
(0.43–1.17) | (0.65–2.57) | (0.41–1.22) | |
Socio-demographic and clinical characteristic adjusted†† | 0.59 | 0.84 | 0.38 |
(0.34–1.04) | (0.37–1.88) | (0.20–0.73) | |
BMI between 25 and <30 kg/m 2 versus referent group BMI <25 kg/m 2 | |||
Crude | 0.68 | 1.29 | 0.77 |
(0.50–0.94) | (0.83–2.01) | (0.55–1.09) | |
Socio-demographic adjusted† | 0.49 | 0.78 | 0.52 |
(0.31–0.80) | (0.39–1.55) | (0.31–0.88) | |
Socio-demographic and clinical characteristic adjusted†† | 0.47 | 0.75 | 0.35 |
(0.28–0.79) | (0.35–1.63) | (0.19–0.65) |